Christine Schmitz

7PUBLICATIONS
19CO-AUTHORS
ChiropracticGene and molecular therapyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2025
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial.

Ulrich Dührsen, Gabriele Prange-Krex, Regina Moeller

|Apr 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

Jan H Frenking, Christine Riedhammer, Raphael Teipel

|Jan 17, 2025
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study.

Maximilian Merz, Anca-Maria Albici, Bastian von Tresckow

|Nov 21, 2024
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.

Elias K Mai, Axel Nogai, Henk M Lokhorst

|Oct 28, 2021
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial.

Martina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller

|Sep 14, 2020
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy.

Christine Schmitz, Jan Rekowski, Stefan P Müller

Pageof 2

Frequent Collaborators

3 joint publications

Andreas Hüttmann

3 joint publications

Ulrich Dührsen

2 joint publications

Jan Rekowski

2 joint publications

Maximilian Merz